Lymphoma Clinical Trial
Official title:
A Comparison of Exercise Training With Relaxation Intervention in Lymphoma Patients Post-chemotherapy.
This study will aim to compare the effects of an Exercise programme and a Relaxation
Intervention in lymphoma patients in remission post-chemotherapy on quality of life,
cardiovascular fitness, exercise tolerance, muscle strength, psychological status, social
well-being and biological markers.
Subjects will be recruited from a specialist lymphoma clinic in South West London and
randomly allocated to an exercise or a relaxation home programme. The study aims to determine
the more effective intervention of the two in relation to the outcome measures.
The investigators anticipate that the interventions will result in less adverse events and
improved quality of life and physical fitness, and subjects will require less medication,
less counseling and cancer nurse specialist care, leading to leading to a reduction in
hospital and surgery attendances.
Significant improvements have been made in the survival rates in cancer patients. Due to
factors such as screening and earlier detection of cancer and advances in treatment, cancer
today is a curable disease for many. However, cancer survivors are at a significantly
increased risk of morbidity and adverse effects due to treatment exposures. Commonly reported
consequences of cancer treatment include fatigue, pain, depression, anxiety, reduced
performance status and decreased quality of life Hence cancer today is considered more as a
chronic illness, and there is increasing research being carried out on cancer survivorship
and recommendations for survivorship care pathways to include interventions to enhance both
physical and psychosocial functioning in cancer survivors.
Previous studies have demonstrated that both exercise and interventions such as relaxation
have a positive effect on both physical and psychosocial complaints of cancer survivors.
These interventions are carried out in different ways, have different requirements and
perceptions of the two can also be very different. No trial to date has been carried out
comparing the effects of these interventions on the quality of life in cancer survivors.
Furthermore, majority of the above research has been carried out on the most prevalent
cancers including breast cancer, prostate cancer and colorectal cancer, and several authors
have called for future research to focus on other understudied survivor groups, including
haematologic cancer sites. This study aims to compare the effect of exercise and relaxation
interventions on quality of life in lymphoma survivors.
The aim of the present study is to compare the effects of an Exercise Intervention Program
with a Relaxation Intervention in a sample of lymphoma patients in remission
post-chemotherapy.
Eligible subjects will be randomised to one of two arms - either an exercise or a relaxation
arm. Both arms comprise of a home programme of their intervention (either exercise or
relaxation) for half an hour, carried out three times a week. Subjects are assessed using the
primary and secondary outcome measures at baseline, midway (6 weeks) and at the end of the
intervention (12 weeks). It is hypothesised that a 12 week training programme of both
exercise and relaxation would improve the quality of life of lymphoma survivors, however the
exercise programme would result in a significantly greater improvement than relaxation. The
null hypothesis would state that there would be no significant difference between exercise or
relaxation groups following a 12 week training programme in lymphoma survivors.
The aims of the study are as follows:
Primary aim
To compare the effectiveness of Exercise with Relaxation in the improvement of overall
wellbeing and quality of life using the European Organisation for Research and Treatment of
Cancer Quality of Life Questionnaire Core 30 (EORTC-QLQ-C30).
Secondary aims
To determine whether these interventions result in:
- Improved cardio-respiratory fitness (resting HR and BP) and pulmonary function
(spirometry)
- Improved fitness and exercise tolerance using the 6 Minute Walk Test
- Improved emotional and functional confidence as measured by the Health related quality
of life questionnaire Functional Assessment of Cancer Therapy Lymphoma version
(FACT-Lym)
- Decreased anxiety and depression levels using the Hospital Anxiety and Depression Scale
(HADS)
- Changes in haematology (haemoglobin, immunoglobulins, white count) and biochemical
(serum albumin, corrected calcium, creatinine) parameters
- Compare the results of the above outcome measures between the two interventions
- Analyse subject perceptions of interventions in focus groups
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05540340 -
A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant
|
N/A | |
Completed |
NCT01947140 -
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
|
Phase 1/Phase 2 | |
Completed |
NCT00001512 -
Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
|
Phase 1 | |
Recruiting |
NCT05618041 -
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
|
N/A | |
Completed |
NCT01410630 -
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
|
||
Active, not recruiting |
NCT04270266 -
Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With Lymphoma
|
N/A | |
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT01949883 -
A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma
|
Phase 1 | |
Completed |
NCT01682226 -
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
|
Phase 2 | |
Completed |
NCT00003270 -
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
|
Phase 2 | |
Recruiting |
NCT04904588 -
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
|
Phase 2 | |
Recruiting |
NCT05019976 -
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
|
N/A | |
Completed |
NCT04434937 -
Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213)
|
Phase 2 | |
Completed |
NCT01855750 -
A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
|
Phase 3 | |
Terminated |
NCT00788125 -
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT00775268 -
18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04188678 -
Resiliency in Older Adults Undergoing Bone Marrow Transplant
|
N/A | |
Terminated |
NCT00014560 -
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Recruiting |
NCT04977024 -
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
|
Phase 2 | |
Active, not recruiting |
NCT03936465 -
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
|
Phase 1 |